Mohammed Nizam, MD
Neurology with Special Qualifications in Child Neurology · Edison, NJNPI 1326145764
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 87.4% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $143, more than ten times the $2 reported in 2019. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in NJ, where the typical reported total is $394.
Across 38 payments — averaging $8.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$270
- Livanova USA, Inc.$13
- Biohaven Pharmaceutical Holding Company Ltd.$12
- Biohaven Pharmaceuticals, Inc.$11
- Travere Therapeutics, Inc.$2
What the payments were for
- Food & beverage$30799%
- Education$21%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $270 |
| Livanova USA, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
| Travere Therapeutics, Inc. | 2 | $2 |
How this compares
$309 in reported general payments places this provider in the 40th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 27 | $715,533 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 39 | $568,364 |
| UbrelvyUbrogepant | 105 | $105,800 |
| Avonex (4 Pack)Interferon Beta-1a | 13 | $103,545 |
| NuplazidPimavanserin Tartrate | 11 | $54,253 |
| Nurtec OdtRimegepant Sulfate | 49 | $47,211 |
| QuliptaAtogepant | 42 | $45,340 |
| AptiomEslicarbazepine Acetate | 12 | $14,835 |
| Aspirin-Dipyridamole ErAspirin/Dipyridamole | 18 | $7,371 |
| Levetiracetam | 131 | $5,003 |
| DilantinPhenytoin Sodium Extended | 18 | $4,929 |
| Gabapentin | 193 | $4,048 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 185 | $3,239 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 65 | $3,192 |
| Pyridostigmine Bromide ErPyridostigmine Bromide | 12 | $2,945 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $270 | $151,140147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
Other neurology with special qualifications in child neurology in Edison
- Yongming MaoEdison$2K
- Savitra BandariEdison$1K
- Juliann PaolicchiHackensack$80K
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Aliza AlterLivingston$9K
- Sara RubensteinHackensack$7K
- Carlos LastraNew Brunswick$5K
- Jacqueline RomeroMarlboro$4K
- Sohum TrivediMarlboro$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.